PATENT CLAIM ANALYSIS

Application Number: 15957835
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "197110"]

Abstract:
The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.

Claim (Index 51):
The method according to  claim 46 , wherein the immunogen further comprises a CGG between the N-terminus of the PCSK9 peptide and C-terminus of the carrier.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.34146
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14508977', '15266812', '15118143', '14225258', '13152032']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7847034737505191
- 35 USC 102 Novelty (BERT): 0.6291478218264172
- Combined Prediction Score: 0.7691479085581089
- Mean Citation Score: 515.8078459999998
- Max Citation Score: 668.9936
- Similarity Product: 501.8196867351532

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test